Type / Class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Shares outstanding
264M
Number of holders
32
Total 13F shares, excl. options
9.4M
Shares change
+401K
Total reported value, excl. options
$22.7M
Value change
+$2.03M
Put/Call ratio
0
Number of buys
14
Number of sells
-15
Price
$2.42

Significant Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q2 2025

41 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q2 2025.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.4M shares of 264M outstanding shares and own 3.55% of the company stock.
Largest 10 shareholders include HHLR ADVISORS, LTD. (5.98M shares), Candriam S.C.A. (1.13M shares), SG Americas Securities, LLC (876K shares), TWO SIGMA ADVISERS, LP (209K shares), UBS Group AG (185K shares), Aberdeen Group plc (136K shares), BNP PARIBAS FINANCIAL MARKETS (122K shares), TWO SIGMA INVESTMENTS, LP (113K shares), Ariose Capital Management Ltd (96.5K shares), and Alberta Investment Management Corp (74.7K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.